scholarly journals A nurse-led conceptual model to inform patient-centred, type 2 diabetes mellitus management in public clinical settings

2021 ◽  
Vol 26 (8) ◽  
pp. 763-778
Author(s):  
Stella Foluke Bosun-Arije ◽  
Candidus Chibuzor Nwakasi ◽  
Mandu Ekpenyong ◽  
Laura Serrant ◽  
Temitope Esther Sunday-Abel ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Conceptual Model ◽  
Healthcare Delivery ◽  
Public Hospitals ◽  
Clinical Settings ◽  
Patient Centred Care ◽  
Diabetes Mellitus Management

Background Globally, there is an increased need to provide patient-centred care for people diagnosed with type 2 diabetes mellitus. In Nigeria, a poorly financed health system has worsened the difficulties associated with managing type 2 diabetes mellitus in clinical settings, causing a detrimental effect on patient-centred care. Aims We aimed to develop a conceptual model to promote patient-centred type 2 diabetes mellitus care in clinical settings. We explored nurses’ contextual perceptions of clinical practices and operations in light of type 2 diabetes mellitus management across public hospitals in Lagos, Nigeria. Identifying a nurse-led intervention is critical to care optimisation for people diagnosed with type 2 diabetes mellitus. Methods We adopted a qualitative approach. Using the constant comparison method and semi-structured questions and interviewed practice nurses, with over one year’s experience and who were working in public hospitals across Lagos, Nigeria. The framework method was used to analyse the data obtained. Results Nurses provided insight into four areas of patient-centred type 2 diabetes mellitus management in clinical settings: empowering collaboration; empowering flexibility; empowering approach; and empowering practice. Nurses discussed an empowering pathway through which health settings could provide patient-centred care to individuals diagnosed with type 2 diabetes mellitus. The pathway entailed the integration of macro, meso and micro levels for patient management. Nurses’ accounts have informed the development of a conceptual model for the optimisation of patient care. Conclusions The model developed from this research sits within the patient-centred care model of healthcare delivery. The research sits within the patient-centred care model of healthcare delivery. inform patient-centred care, not only in countries with poorly financed healthcare systems, but in developed countries with comparatively better healthcare.

Type 2 diabetes mellitus management in patients with chronic kidney disease: an update

HORMONES ◽  
2020 ◽  
Vol 19 (4) ◽  
pp. 467-476
Author(s):  
Zoi Kleinaki ◽  
Stella Kapnisi ◽  
Sofia-Andriani Theodorelou-Charitou ◽  
Ilias P. Nikas ◽  
Stavroula A. Paschou
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Type 2 Diabetes Mellitus ◽  
Kidney Disease ◽  
Diabetes Mellitus Management

scholarly journals On the Role of Spirituality and Religiosity in Type 2 Diabetes Mellitus Management—A Systematic Review

Psychology ◽  
2018 ◽  
Vol 09 (04) ◽  
pp. 728-744 ◽  
Author(s):  
Panagiota Darvyri ◽  
Stavros Christodoulakis ◽  
Michael Galanakis ◽  
Adamantios G. Avgoustidis ◽  
Anastasia Thanopoulou ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Systematic Review ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Diabetes Mellitus Management

scholarly journals Management of type 2 diabetes mellitus: insights into prescribing trends

2017 ◽  
Vol 5 (4) ◽  
pp. 1306 ◽  
Author(s):  
Prasanna Kumar K. M. ◽  
Shahu Ingole ◽  
Tushar Tamboli ◽  
Rishi Jain
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Safety Data ◽  
Clinical Settings ◽  
Efficacy Data ◽  
Cross Sectional ◽  
Prescribing Trends ◽  
Improved Glycaemic Control

Background: Recently, management of type 2 diabetes mellitus (T2DM) has changed with advent of novel agents like DPP4i, SGLT2i and GLP-1 agonist. Of these, DPP4i have emerged as promising agents as monotherapy and as an add-on to metformin for improved glycaemic control.  This survey was planned to explore current prescribing trends of physicians of India for the management of T2DM.Methods: This was a prospective, cross sectional, questionnaire-based survey of physicians and endocrinologist across different geographic areas in India. A survey questionnaire consisting of 10 questions related to management of T2DM in real-world clinical settings was prepared, validated in a small group of physicians and then administered to physicians and endocrinologists.Results: Responses from 502 physicians were received. About 60% physicians prefer DPP4i as first add-on to metformin followed by sulfonylurea (SU) (30%). Amongst DPP4i, vildagliptin and sitagliptin were preferred by 48% and 28% physicians respectively as first add-on to metformin. For patients uncontrolled on metformin + SU therapy, 54 % physicians prefer DPP4i as second add-on. Vildagliptin is perceived to have the better efficacy and safety data, as suggested by 40% and 43% physicians respectively. Large number of physicians (48%) were hesitant to prescribe teneligliptin due to insufficient data. SGLT2 inhibitors are preferred as third add-on by 44% physicians.Conclusions: DPP4i are being increasingly preferred by physician as an add-on to metformin. Among DPP4i, the survey revealed that vildagliptin is the most preferred DPP4i as an add-on to metformin possibly owing to its established safety and efficacy data.

scholarly journals Experience in using nucleotides for the management Of patients with diabetic polyneuropatie

2018 ◽  
pp. 24-28
Author(s):  
G. N. Belskaya ◽  
L. G. Krylova ◽  
L. A. Sergienko ◽  
S. B. Stepanova ◽  
L. D. Makarova
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Diabetic Polyneuropathy ◽  
Control Group ◽  
Basic Therapy ◽  
Neuropathic Symptom ◽  
Study Results ◽  
Diabetes Mellitus Management

Diabetic polyneuropathy (DPN) is one of the most common complications of diabetes mellitus. Management of patients with DPN is a complex medical and socioeconomic problem. The article presents the observational study results of 40 patients with type 2 diabetes mellitus complicated by DPN. Patients of the treatment group received Keltikan® complex in combination with basic therapy for 60 days, patients of the control group received only basic therapy. The treatment resulted in the positive changes observed in both groups, while the group taking Keltikan® complex showed more pronounced changes according to the total neurological symptoms (TSS) scale, the neuropathic dysfunctional score (NDS) scale, the neuropathic symptom score (NSS) scale, and also according to the electroneuromyography results. 

Sign in / Sign up

Export Citation Format

Share Document